1. Home
  2. HUMA vs LBRX Comparison

HUMA vs LBRX Comparison

Compare HUMA & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • LBRX
  • Stock Information
  • Founded
  • HUMA 2004
  • LBRX 2015
  • Country
  • HUMA United States
  • LBRX United States
  • Employees
  • HUMA N/A
  • LBRX N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • LBRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUMA Health Care
  • LBRX Health Care
  • Exchange
  • HUMA Nasdaq
  • LBRX Nasdaq
  • Market Cap
  • HUMA 324.0M
  • LBRX 337.7M
  • IPO Year
  • HUMA N/A
  • LBRX 2025
  • Fundamental
  • Price
  • HUMA $1.33
  • LBRX $16.46
  • Analyst Decision
  • HUMA Strong Buy
  • LBRX Strong Buy
  • Analyst Count
  • HUMA 8
  • LBRX 3
  • Target Price
  • HUMA $10.13
  • LBRX $46.33
  • AVG Volume (30 Days)
  • HUMA 5.0M
  • LBRX 116.8K
  • Earning Date
  • HUMA 11-12-2025
  • LBRX 11-06-2025
  • Dividend Yield
  • HUMA N/A
  • LBRX N/A
  • EPS Growth
  • HUMA N/A
  • LBRX N/A
  • EPS
  • HUMA N/A
  • LBRX N/A
  • Revenue
  • HUMA $1,571,000.00
  • LBRX N/A
  • Revenue This Year
  • HUMA N/A
  • LBRX N/A
  • Revenue Next Year
  • HUMA $1,468.13
  • LBRX N/A
  • P/E Ratio
  • HUMA N/A
  • LBRX N/A
  • Revenue Growth
  • HUMA N/A
  • LBRX N/A
  • 52 Week Low
  • HUMA $1.09
  • LBRX $13.36
  • 52 Week High
  • HUMA $6.77
  • LBRX $20.25
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 46.13
  • LBRX N/A
  • Support Level
  • HUMA $1.09
  • LBRX N/A
  • Resistance Level
  • HUMA $1.26
  • LBRX N/A
  • Average True Range (ATR)
  • HUMA 0.11
  • LBRX 0.00
  • MACD
  • HUMA 0.02
  • LBRX 0.00
  • Stochastic Oscillator
  • HUMA 69.12
  • LBRX 0.00

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: